MetLife, Inc. (LON:0K0X)
London
· Delayed Price · Currency is GBP · Price in USD 80.50
+2.47 (3.16%)
At close: May 12, 2025
MetLife Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Premiums & Annuity Revenue | 51,570 | 49,919 | 49,435 | 53,735 | 46,396 | 47,637 | Upgrade
|
| Total Interest & Dividend Income | 19,659 | 20,127 | 19,404 | 14,994 | 21,326 | 16,048 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,135 | -1,152 | -2,727 | -1,065 | 1,596 | -115 | Upgrade
|
| Other Revenue | 3,400 | 2,088 | 789 | 1,100 | -630 | 4,272 | Upgrade
|
| Total Revenue | 73,494 | 70,982 | 66,901 | 68,764 | 68,688 | 67,842 | Upgrade
|
| Revenue Growth (YoY) | 8.77% | 6.10% | -2.71% | 0.11% | 1.25% | -2.55% | Upgrade
|
| Policy Benefits | 54,533 | 53,456 | 53,027 | 54,221 | 49,397 | 47,765 | Upgrade
|
| Other Operating Expenses | 12,120 | 11,981 | 11,667 | 10,922 | 11,100 | 12,239 | Upgrade
|
| Total Operating Expenses | 66,653 | 65,437 | 64,694 | 65,143 | 60,497 | 60,004 | Upgrade
|
| Operating Income | 6,841 | 5,545 | 2,207 | 3,621 | 8,191 | 7,838 | Upgrade
|
| Interest Expense | -1,031 | -1,037 | -1,045 | -938 | -920 | -913 | Upgrade
|
| Currency Exchange Gain (Loss) | 5 | 5 | 6 | 7 | 10 | 2 | Upgrade
|
| Other Non Operating Income (Expenses) | 116 | 1,109 | 994 | 3,674 | 1,237 | - | Upgrade
|
| EBT Excluding Unusual Items | 5,931 | 5,622 | 2,162 | 6,364 | 8,518 | 6,927 | Upgrade
|
| Pretax Income | 5,931 | 5,622 | 2,162 | 6,364 | 8,518 | 6,927 | Upgrade
|
| Income Tax Expense | 1,412 | 1,178 | 560 | 1,062 | 1,642 | 1,509 | Upgrade
|
| Earnings From Continuing Ops. | 4,519 | 4,444 | 1,602 | 5,302 | 6,876 | 5,418 | Upgrade
|
| Net Income to Company | 4,519 | 4,444 | 1,602 | 5,302 | 6,876 | 5,418 | Upgrade
|
| Minority Interest in Earnings | -15 | -18 | -24 | -18 | -21 | -11 | Upgrade
|
| Net Income | 4,504 | 4,426 | 1,578 | 5,284 | 6,855 | 5,407 | Upgrade
|
| Preferred Dividends & Other Adjustments | 199 | 200 | 198 | 185 | 201 | 216 | Upgrade
|
| Net Income to Common | 4,305 | 4,226 | 1,380 | 5,099 | 6,654 | 5,191 | Upgrade
|
| Net Income Growth | 90.44% | 180.48% | -70.14% | -22.92% | 26.78% | -8.34% | Upgrade
|
| Shares Outstanding (Basic) | 696 | 706 | 758 | 803 | 863 | 908 | Upgrade
|
| Shares Outstanding (Diluted) | 701 | 711 | 762 | 809 | 869 | 913 | Upgrade
|
| Shares Change (YoY) | -6.45% | -6.72% | -5.76% | -6.96% | -4.80% | -3.30% | Upgrade
|
| EPS (Basic) | 6.18 | 5.98 | 1.82 | 6.35 | 7.71 | 5.72 | Upgrade
|
| EPS (Diluted) | 6.14 | 5.94 | 1.81 | 6.30 | 7.65 | 5.68 | Upgrade
|
| EPS Growth | 112.38% | 228.18% | -71.27% | -17.65% | 34.68% | -6.27% | Upgrade
|
| Dividend Per Share | 2.180 | 2.155 | 2.060 | 1.980 | 1.900 | 1.820 | Upgrade
|
| Dividend Growth | 4.81% | 4.61% | 4.04% | 4.21% | 4.40% | 4.60% | Upgrade
|
| Operating Margin | 9.31% | 7.81% | 3.30% | 5.27% | 11.92% | 11.55% | Upgrade
|
| Profit Margin | 5.86% | 5.95% | 2.06% | 7.41% | 9.69% | 7.65% | Upgrade
|
| EBITDA | 7,555 | 6,259 | 2,925 | 4,294 | 8,885 | 8,250 | Upgrade
|
| EBITDA Margin | 10.28% | 8.82% | 4.37% | 6.25% | 12.93% | 12.16% | Upgrade
|
| D&A For EBITDA | 714 | 714 | 718 | 673 | 694 | 412 | Upgrade
|
| EBIT | 6,841 | 5,545 | 2,207 | 3,621 | 8,191 | 7,838 | Upgrade
|
| EBIT Margin | 9.31% | 7.81% | 3.30% | 5.27% | 11.92% | 11.55% | Upgrade
|
| Effective Tax Rate | 23.81% | 20.95% | 25.90% | 16.69% | 19.28% | 21.78% | Upgrade
|
| Revenue as Reported | 73,498 | 70,986 | 66,905 | 68,770 | 68,696 | 67,842 | Upgrade
|
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.